Aurwest Resources Corp logo

Aurwest Resources Corp (AWR)

Market Closed
10 Dec, 20:00
CNSX CNSX
CA$
0. 01
0
0%
CA$
- Market Cap
- P/E Ratio
0% Div Yield
35,000 Volume
0 Eps
CA$ 0.01
Previous Close
Day Range
0.01 0.01
Year Range
0.01 0.03
Want to track AWR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 1 days

Summary

AWR closed Wednesday higher at CA$0.01, an increase of 0% from Tuesday's close, completing a monthly increase of 50% or CA$0. Over the past 12 months, AWR stock gained 200%.
AWR is not paying dividends to its shareholders.
The last earnings report, released on Dec 08, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Dec 15, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on CNSX (CAD).

AWR Chart

Aurwest Resources Corp (AWR) FAQ

What is the stock price today?

The current price is CA$0.01.

On which exchange is it traded?

Aurwest Resources Corp is listed on CNSX.

What is its stock symbol?

The ticker symbol is AWR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Dec 15, 2025.

Has Aurwest Resources Corp ever had a stock split?

No, there has never been a stock split.

Aurwest Resources Corp Profile

Insurance Industry
Financials Sector
Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. CEO
CNSX Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
8 Jan 2020 Last Split
- IPO Date

Overview

PainChek Limited is an innovative company based in Sydney, Australia, specializing in the development and commercialization of mobile medical device applications aimed at providing comprehensive pain assessment solutions. The company primarily operates in Australia, the United Kingdom, and other international markets. Initially known as ePAT Technologies Ltd, the organization rebranded to PainChek Limited in January 2018. PainChek Limited's mission is to enhance the quality of care for individuals unable to communicate their pain effectively, including those with dementia, pre-verbal infants, and patients in various care sectors such as aged care, disability, home care, hospitals, and the infant sector.

Products and Services

PainChek's offerings focus on leveraging technology to assess and manage pain in individuals who cannot verbally communicate their pain levels. The company's flagship product and services include:

  • PainChek: This innovative mobile application utilizes the cameras in smartphones and tablets to conduct facial scans of patients. The application then analyzes these scans in real-time using advanced facial recognition software. This process effectively identifies and indicates the presence of pain by interpreting facial expressions, providing a reliable, objective measure of pain. The application serves an essential function for several key demographics:

- Patients suffering from dementia: For individuals with dementia who may have difficulty expressing their pain verbally, PainChek offers a non-verbal solution to assess their pain levels accurately.

- Pre-verbal infants: Infants who are not yet able to speak can also benefit from PainChek's technology, ensuring their pain is recognized and managed appropriately.

The application is designed to support various sectors including aged care facilities, disability services, home care providers, hospitals, and infant care settings, making it a versatile tool in improving patient care and pain management strategies.

Contact Information

Address: 35 Lime Street
Phone: 61 4 2125 2123